Biocon sees a sweet spot with its affordable insulin in US
The biotech firm is also planning to provide its rh-insulin to middle- and low-income countries at less than 10 cents a day. Biocon Biologics is chasing a revenue target of $1 billion in financial year 2021-22. In the previous fiscal year, its revenue had topped $200 million.
Volume with low cost is Biocon Biologics’ big plan
The Biocon subsidiary will chart a path that ensures high volumes and low costs, unlike co...
Parliamentary panel recommends integration of Indian Systems of Medicine with modern treatment
The Department-related Parliamentary Standing ...
Glenmark Pharma gets USFDA nod for diabetes management drug
"Glenmark Pharmaceuticals Inc, USA, has been granted final approval by the United States Food & Drug Administration (USFDA) for metformin hydrochloride extended release tablets USP, 500 mg and 1000 mg, the generic version of Glumetza extended release tablets, 500 mg and 1,000 mg, of Salix Pharmaceuticals Inc," the drug maker said in a filing to BSE.
Belly fat bringing you down? Lower risk of age-related diseases by burning it
The human body's ability to generate energy by burning the belly fat reduces with age.
Unable to afford insulin? This WHO initiative aims at helping diabetics by slashing prices
There are currently more than 420 million diabetic adults in the world.
World Diabetes Day: Diabetic shock can lead to seizures, coma: Never skip or delay a meal, eat enough
Visit a doctor if you feel irritable, anxious, and have disrupted sleep.
Diabetes can make your toes numb and affect walking ability: Quit smoking, have Vitamin B12-rich diet
Toe numbness may also lead to injuries and wounds.
Why India should seriously pay attention to its children's pre-diabetes
A new national survey shows 10% of children are at risk of developing diabetes. Policies must focus on getting them to eat right and exercise. In 2016, diabetes was directly responsible for 1.6 million deaths around the world, according to the WHO. The new data comes even as India is struggling with a diabetic population of over 72 million.
Are you exercising enough? Lack of physical activity may up early death risk in adults
Physical activity is known to reduce deaths from heart disease and diabetes.
Macleods Pharma USA Inc recalls 31,968 bottles of diabetes drug in US
Macleods Pharma USA Inc has declared Pioglitazone Hydrochloride tablets used for treatment of diabetes in America to be superpotent which was manufactured in Baddi, Himachal Pradesh. The product was shipped to 8 distributors in US, USFDA reported.
Spending hours on an iPad? It could be the reason why you're addicted to coffee
Teens spending more time using gadgets are more likely to binge on sugary drinks.
Drug sales reveal our lifestyle woes
Indians spent over Rs 1,36,000 cr on medicines in last one year ending September 2019. People spent over Rs 17,000 cr on cardiac drugs, around Rs 15,400 cr for gastro-intestinal disorders and over Rs 13,360 crore on anti-diabetes medicines .
Watch your weight: Obesity during mid-20s may up early death risk
Weight loss over this period was not significantly related to mortality.
Medical marvel: New AI system can accurately detect diabetic retinopathy
The screening system can provide a reading in just 60 seconds.
Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service